Another 'BEE'? - Brain-Eye-Ear (BEE) Disease Secondary to HbSC Disease Masquerading as Multiple Sclerosis

Asya Izraelit Wallach1, Maria J Borja2, Duan Chen2

  • 1Former Affiliation/Place Clinical Care was provided: NYU MS Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, USA; Current Affiliation/ Place Manuscript was written: Alfiero and Lucia Palestroni MS Comprehensive Care Center, Holy Name Medical Center, New Jersey, USA.

Insights

A rare genetic condition mimicked multiple sclerosis (MS) in a patient for 20 years. Genetic testing identified the correct diagnosis, highlighting the importance of considering alternative diagnoses in atypical neurological cases.

Area of Science:

  • Neuroscience
  • Genetics
  • Ophthalmology

Background:

  • Recurrent neurological dysfunction and white matter lesions in young adults often suggest multiple sclerosis (MS).
  • Atypical symptoms such as occlusive retinopathy and hearing loss, alongside absent cerebrospinal fluid (CSF) oligoclonal bands, warrant consideration of alternative diagnoses.
  • Misdiagnosis can lead to prolonged, incorrect treatment and delayed definitive care.

Observation:

  • A male patient presented with a 20-year history of neurological symptoms, including visual disturbances and hearing loss.
  • He exhibited an accumulating burden of brain lesions consistent with demyelinating disease.
  • The patient was clinically diagnosed and treated for multiple sclerosis (MS) for nearly two decades.

Findings:

  • Despite the prolonged MS diagnosis, specific clinical features were inconsistent with typical MS.
  • Genetic testing was performed to investigate the underlying cause of the patient's persistent neurological symptoms.
  • Genetic analysis revealed a unifying diagnosis, explaining the constellation of symptoms and lesions.

Implications:

  • This case underscores the importance of comprehensive diagnostic evaluation, including genetic testing, in cases with atypical presentations of neurological disorders.
  • Recognizing and diagnosing rare genetic mimics of MS is crucial for appropriate patient management and treatment.
  • Accurate diagnosis prevents prolonged exposure to ineffective therapies and allows for targeted interventions, improving patient outcomes.